BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/27/2022 2:48:54 AM | Browse: 318 | Download: 759
 |
Received |
|
2021-09-28 09:29 |
|
Peer-Review Started |
|
2021-09-28 09:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-18 20:49 |
|
Revised |
|
2021-11-29 09:28 |
|
Second Decision |
|
2022-06-29 03:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-30 22:55 |
|
Articles in Press |
|
2022-06-30 22:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-06-25 20:01 |
|
Typeset the Manuscript |
|
2022-07-15 06:40 |
|
Publish the Manuscript Online |
|
2022-07-27 02:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yiyoung Kwon, Eun sil Kim, Yon Ho Choe and Mi Jin Kim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mi Jin Kim, MD, PhD, Associate Professor, Pediatrics, Samsung Medical Center, Ilwon-ro 81, Gangnam-gu, Seoul 06351, South Korea. mijin1217.kim@samsung.com |
| Key Words |
Colitis; Ulcerative; Children; Infliximab; Relapse; Steroid |
| Core Tip |
This was a retrospective study that assessed how the introduction of biological agents has altered the disease course over time in pediatric ulcerative colitis (UC). Endoscopic remission, relapse rate, steroid-free period, and the quality of life of each group were evaluated as outcomes. Clinical course was plotted with the pediatric UC activity index score, and compared to that of the IBSEN study. The incidence of relapse has decreased and the steroid-free period has increased after the introduction of biological agents. The clinical course also showed a different pattern from the IBSEN study. |
| Publish Date |
2022-07-27 02:48 |
| Citation |
Kwon Y, Kim E, Choe YH, Kim MJ. How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study. World J Gastroenterol 2022; 28(28): 3666-3681 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i28/3666.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i28.3666 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
